Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

April 6, 2020

Mayo Clinic Research in the News — Week in Review 4/6/2020

By Elizabeth Zimmermann

In the last week, as you might imagine, most of the news being covered by the media is about COVID-19. We've included an excerpt and link to several of these stories discussing Mayo Clinic Research.

We found a couple items covering other things we are working on, so included them first, for your awareness.

Study: New Blood Test Can Detect Wide Range of Cancers

By Jill Murphy, Assistant Editor, Pharmacy Times, 4/6/2020

A new blood test has detected more than 50 types of cancer as well as their location within the body, according to an international team of researchers led by the Dana-Farber Cancer Institute and the Mayo Clinic.

The results indicate that the test can play a key role in the early detection of cancer, since it is able to identify some particularly dangerous cancers that lack standard approaches to screening and help with a more successful treatment.

Research reveals how pain could be a growing threat to surgeons via HealthDay, 4/6/2020

Many surgeons have neck and back pain after performing operations, a small new study finds.

It included 53 surgeons (34 men and 19 women) who did 116 operations at the Mayo Clinic in Phoenix. They wore devices that measured neck, back and arm posture during surgery, and were asked about pain and fatigue levels before and after.

Mayo Clinic to lead national COVID-19 plasma trial 

By Jeremy Olson, Star Tribune, 4/3/2020

Mayo Clinic announced Friday it is leading a national trial to use donated plasma from patients who have recovered from COVID-19 as a treatment for others infected by the novel coronavirus that causes the illness.

The cooperative effort with 40 institutions in 20 states could verify a vital treatment, given that nobody has immunity against the coronavirus that has quickly spread across the globe.

Why U.S. Hospitals See Promise in Plasma From New Coronavirus Patients

By Deena Beasley, U.S.News via Reuters, 4/4/2020

U.S. hospitals desperate to help very sick patients with COVID-19, the highly contagious respiratory disease caused by the new coronavirus, are trying a treatment first used in the 1890s that relies on blood plasma donated by recovered patients.

Researchers work around the clock developing COVID-19 vaccine at Mayo Clinic 

By Dani Bozzini, Action News Jax, 4/3/2020

While the numbers of COVID 19 cases continue to rise in the U.S., researchers are working around the clock to develop a vaccine.

Mayo Clinic says they’re very involved in the process, although a vaccine is still quite a ways away.

Are you already immune to COVID-19? Mayo releases critical new test to find out

By Paul John Scott, Post Bulletin, 4/3/2020

Mayo Clinic Laboratories says it plans to release their long-awaited coronavirus serology test on Monday, April 6 That's one month from the first confirmed case of coronavirus in the state, and the result of a nonstop initiative within the clinic's commercial laboratory enterprise to procure a test capable of determining whether a person has been exposed to the coronavirus.  

Disease data modeling, in Minnesota and elsewhere, varies greatly

By Jeremy Olson, Star Tribune, 4/2/2020

“It’s not really that one model is that much better or that much worse,” said Dr. Henry Ting at Mayo Clinic, which has examined 13 COVID-19 models in the development of its own. “The key is the assumptions you’re putting into these models. Those are driving the differences.”

COVID-19: Mayo Clinic expert perspective on death projections

By Andy Brownell, KROC Radio, 4/2/2020

A prominent Mayo Clinic infectious disease expert says he considers government projections of over 100,000 and up to 240,000 COVID 19 deaths in the United States represent a worst-case scenario. Doctor Gregory Poland is with the Mayo Clinic Vaccine Research Group and spoke out the issue in an effort to put the grim statistics in perspective. 

FDA authorizes widespread use of unproven drugs to treat coronavirus, saying possible benefit outweighs risk

By Christopher Rowland, Washington Post, 3/30/2020

The Food and Drug Administration has given emergency approval to a Trump administration plan to distribute millions of doses of anti-malarial drugs to hospitals across the country, saying it is worth the risk of trying unproven treatments to slow the progression of the disease caused by the novel coronavirus in seriously ill patients. …

“The concern really is if we’re talking millions of patients, then this issue of drug-induced sudden cardiac death is absolutely going to rear its ugly head,’’ said Michael Ackerman, a pediatric cardiologist and professor at the Mayo Clinic College of Medicine and Science, who last week co-authored a key paper about the risks in response to the surge in the drugs’ use.


For Mayo Clinic stories, videos, podcasts and other current resources related to COVID-19, visit our mini site.

STAY CONNECTED — Advancing the Science

  • If you enjoyed this article, you might want to subscribe for regular updates.
  • If you want to share this story with friends, social media links are at the top of the article.
  • And if you want to see other recent stories on the blog, the index page is a great place to start.

Tags: blood test, cancer, cancer screening, cardiology, clinical trials, COVID-19, FDA, Gregory Poland, Henry Ting, immune system, Mayo Clinic Laboratories, Michael Ackerman, News, plasma, sudden cardiac arrest, surgery, vaccines

Please sign in or register to post a reply.
Contact Us · Privacy Policy